NCYT:LON
Novacyt SA
39,50 GBX
arrow_downward
-0,25%(-0,100) 1D
16-окт., 16:35:25 GMT+1 · GBX
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NCYT...
Open
39,60 GBX
High
39,68 GBX
Low
39,20 GBX
Mkt. cap
32,41 млн
Avg. vol.
102,63 миң
Volume
12,22 миң
52-wk high
86,00 GBX
52-wk low
26,60 GBX
Shares outstanding
37,66 млн
No. of employees
228
Open
39,60 GBX
High
39,68 GBX
Low
39,20 GBX
Mkt. cap
32,41 млн
Avg. vol.
102,63 миң
Volume
12,22 миң
52-wk high
86,00 GBX
52-wk low
26,60 GBX
Shares outstanding
37,66 млн
No. of employees
228
News stories
From web sources and news partners
Detroit Free Press
·
16 мүнөт мурун
Memory-chip rout, inflation, CoreWeave: The week on Wall Street
Yahoo Finance
·
48 мүнөт мурун
Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half
Binance
·
38 мүнөт мурун
Binance Market Update | S&P 500 Near a Record While Half the Russell 3000 Is in a Bear Market — Bitcoin Held as AI Credit Spreads Blew Out and Strategy Fell 9%
MarketWatch
·
13 саат мурун
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA